Lieberman David A, Weiss David G, Harford William V, Ahnen Dennis J, Provenzale Dawn, Sontag Stephen J, Schnell Thomas G, Chejfec Gregorio, Campbell Donald R, Kidao Jayashri, Bond John H, Nelson Douglas B, Triadafilopoulos George, Ramirez Francisco C, Collins Judith F, Johnston Tiina K, McQuaid Kenneth R, Garewal Harinder, Sampliner Richard E, Esquivel Romeo, Robertson Douglas
Department of Veterans Affairs Medical Center, Portland, Oregon 97239, USA.
Gastroenterology. 2007 Oct;133(4):1077-85. doi: 10.1053/j.gastro.2007.07.006.
BACKGROUND & AIMS: Outcomes of colon surveillance after colorectal cancer screening with colonoscopy are uncertain. We conducted a prospective study to measure incidence of advanced neoplasia in patients within 5.5 years of screening colonoscopy.
Three thousand one hundred twenty-one asymptomatic subjects, age 50 to 75 years, had screening colonoscopy between 1994 and 1997 in the Department of Veterans Affairs. One thousand one hundred seventy-one subjects with neoplasia and 501 neoplasia-free controls were assigned to colonoscopic surveillance over 5 years. Cohorts were defined by baseline findings. Relative risks for advanced neoplasia within 5.5 years were calculated. Advanced neoplasia was defined as tubular adenoma greater than > or =10 mm, adenoma with villous histology, adenoma with high-grade dysplasia, or invasive cancer.
Eight hundred ninety-five (76.4%) patients with neoplasia and 298 subjects (59.5%) without neoplasia at baseline had colonoscopy within 5.5 years; 2.4% of patients with no neoplasia had interval advanced neoplasia. The relative risk in patients with baseline neoplasia was 1.92 (95% CI: 0.83-4.42) with 1 or 2 tubular adenomas <10 mm, 5.01 (95% CI: 2.10-11.96) with 3 or more tubular adenomas <10 mm, 6.40 (95% CI: 2.74-14.94) with tubular adenoma > or =10 mm, 6.05 (95% CI: 2.48-14.71) for villous adenoma, and 6.87 (95% CI: 2.61-18.07) for adenoma with high-grade dysplasia.
There is a strong association between results of baseline screening colonoscopy and rate of serious incident lesions during 5.5 years of surveillance. Patients with 1 or 2 tubular adenomas less than 10 mm represent a low-risk group compared with other patients with colon neoplasia.
结肠镜检查用于结直肠癌筛查后的结肠监测结果尚不确定。我们开展了一项前瞻性研究,以测定在筛查结肠镜检查后5.5年内患者发生进展期瘤变的发生率。
1994年至1997年间,3121名年龄在50至75岁的无症状受试者在退伍军人事务部接受了筛查结肠镜检查。1171名患有瘤变的受试者和501名无瘤变的对照者被分配接受为期5年的结肠镜监测。队列根据基线检查结果定义。计算5.5年内进展期瘤变的相对风险。进展期瘤变定义为直径大于或等于10mm的管状腺瘤、具有绒毛状组织学特征的腺瘤、具有高级别异型增生的腺瘤或浸润性癌。
895名(76.4%)基线时有瘤变的患者和298名(59.5%)无瘤变的受试者在5.5年内接受了结肠镜检查;无瘤变患者中有2.4%发生了间期进展期瘤变。基线时有瘤变的患者中,有1个或2个直径小于10mm管状腺瘤的患者相对风险为1.92(95%可信区间:0.83 - 4.42),有3个或更多直径小于10mm管状腺瘤的患者相对风险为5.01(95%可信区间:2.10 - 11.96),直径大于或等于10mm管状腺瘤的患者相对风险为6.40(95%可信区间:2.74 - 14.94),绒毛状腺瘤患者相对风险为6.05(95%可信区间:2.48 - 14.71),具有高级别异型增生腺瘤患者相对风险为6.87(95%可信区间:2.61 - 18.07)。
基线筛查结肠镜检查结果与5.5年监测期间严重事件性病变发生率之间存在密切关联。与其他患有结肠瘤变的患者相比,有1个或2个直径小于10mm管状腺瘤的患者属于低风险组。